Incidence of Invasive Breast Cancer in Women Treated with Testosterone Implants: Dayton Prospective Cohort Study, 15-Year Update
Background: Previously published 10-year results (March 2008(March -2018) ) from the Dayton prospective breast cancer prevention study showed a 40% reduction in the incidence of invasive breast cancer in women receiving testosterone or testosterone/ anastrozole combination implant therapy compared to age-matched Surveillance Epidemiology and End Results (SEER) expected incidence rate. Study subjects on therapy were followed through March 2023.
Institutions
- University of Dayton (US)
- National Institutes of Health (US)
- Wright State University (US)
- Agropolis International (FR)
- Dayton Clinical Oncology Program (US)
- Millennium Pain Center (US)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- National Institutes of Health Clinical Center (US)
Publication Details
- Journal
- Advances in Preventive Medicine and Health Care
- Published
- 2025-01-22
- DOI
- https://doi.org/10.29011/2688-996x.101070
- Citations
- 1
- Primary Topic
- Breast Implant and Reconstruction
- Type
- article
- Field-Weighted Citation Impact
- 2.01